Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study

ClinicalTrials.gov ID: NCT05967351

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05967351. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to provide a single clinical study with a uniform approach to monitoring long-term safety and efficacy in participants who received delandistrogene moxeparvovec in a previous clinical study. No study drug will be administered as part of this study.

Study identification

NCT ID
NCT05967351
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sarepta Therapeutics, Inc.
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

Genetic

Eligibility (public fields only)

Age range
Not listed
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2023 (Actual)
Primary completion
Oct 31, 2033 (Estimated)
Completion
Oct 31, 2033 (Estimated)
Last update posted
Feb 6, 2026

2023 – 2033

United States locations

U.S. sites
22
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202 —
UCLA Medical Center Los Angeles California 90095 —
Lucile Packard Children's Hospital Stanford (LPCH) Palo Alto California 94304 —
University of California, Davis Sacramento California 95817 —
Rady Children's Hospital San Diego California 92123 —
Children's Hospital of Colorado Aurora Colorado 80045-7106 —
University of Florida Clinical Research Center Gainesville Florida 32610 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
University of Iowa ICTS Clinical Research Unit Iowa City Iowa 52242 —
The Johns Hopkins Hospital, Rubenstein Child Health Bldg Baltimore Maryland 21287 —
Boston Children's Hospital Boston Massachusetts 02115 —
Washington University School of Medicine St Louis Missouri 63110 —
Columbia University Pediatric Neuromuscular Center New York New York 10032 —
University of Rochester Medical Center Rochester New York 14642 —
Lenox Baker Children's Hospital (Duke University) Durham North Carolina 27705 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Oregon Health and Science University Portland Oregon 97239 —
Chiildren's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Health Specialty Center Dallas Texas 75207 —
University of Utah Health Salt Lake City Utah 84132 —
Children's Hospital of The King's Daughters Norfolk Virginia 23510 —
Children's Hospital Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05967351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2026 · Synced Nov 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.